The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model

References

• Hudson BG, Tryggvason K, Sundaramoorthy M, et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348(25):2543–2556.
   PubMed Web of Science ®Google Scholar
• Suleiman H, Zhang L, Roth R, et al. Nanoscale protein architecture of the kidney glomerular basement membrane. Elife. 2013;2:1–18.
   Web of Science ®Google Scholar
• Gross O, Licht C, Anders HJ, Study Group Members of the Gesellschaft für Pädiatrische Nephrologie, et al. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int. 2012;81(5):494–501.
   PubMed Web of Science ®Google Scholar
• Nozu K, Nakanishi K, Abe Y, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019;23(2):158–168.
   PubMed Web of Science ®Google Scholar
• Omachi K, Miyakita R, Fukuda R, et al. Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model. Clin Exp Nephrol. 2017;21(6):952–960.
   PubMed Web of Science ®Google Scholar
• Rubel D, Frese J, Martin M, et al. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice. Matrix Biol. 2014;34:13–21.
   PubMed Web of Science ®Google Scholar
• Vogel WF, Abdulhussein R, Ford CE. Sensing extracellular matrix: An update on discoidin domain receptor function. Cell Signal. 2006;18(8):1108–1116.
   PubMed Web of Science ®Google Scholar
• Vogel W, Gish GD, Alves F, et al. The Discoidin Domain Receptor Tyrosine Kinases Are Activated by. Collagen. Mole Cell. 1997;1(1):13–23.
   PubMed Web of Science ®Google Scholar
• Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol. 2014;310:39–87.
   PubMed Web of Science ®Google Scholar
• Kerroch M, Guerrot D, Vandermeersch S, et al. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J. 2012;26(10):4079–4091.
   PubMed Web of Science ®Google Scholar
• Gross O, Girgert R, Beirowski B, et al. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biol. Elsevier B.V. 2010;29(5):346–356.
   PubMed Web of Science ®Google Scholar
• Richter H, Satz AL, Bedoucha M, et al. DNA-encoded library-derived DDR1 inhibitor prevents fibrosis and renal function loss in a Genetic Mouse Model of Alport Syndrome. ACS Chem Biol. 2019;14(1):37–49.
   PubMed Web of Science ®Google Scholar
• Rheault MN, Kren SM, Thielen BK, et al. Mouse model of X-linked Alport syndrome. J Am Soc Nephrol. 2004;15(6):1466–1474.
   PubMed Web of Science ®Google Scholar
• Fukuda R, Suico MA, Kai Y, et al. Podocyte p53 limits the severity of experimental Alport Syndrome. J Am Soc Nephrol. 2016;27(1):144–157.
   PubMed Web of Science ®Google Scholar
• Koga T, Kai Y, Fukuda R, et al. Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of alport syndrome. PLoS One. 2012;7(8):e43852–11.
   PubMed Web of Science ®Google Scholar
• Suico MA, Fukuda R, Miyakita R, et al. The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism. J Biol Chem. 2014;289(38):26143–26154.
   PubMed Web of Science ®Google Scholar
• Yokota T, Omachi K, Suico MA, et al. STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model. Nephrol Dial Transplant. 2018;33(2):214–223.
   PubMed Web of Science ®Google Scholar
• Labrador JP, Azcoitia V, Tuckermann J, et al. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep. 2001;2(5):446–452.
   PubMed Web of Science ®Google Scholar
• Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, et al. TGF-β-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci. 2017;18(10):2157.
   PubMed Web of Science ®Google Scholar
• Li X, Bu X, Yan F, et al. Deletion of discoidin domain receptor 2 attenuates renal interstitial fibrosis in a murine unilateral ureteral obstruction model. Ren Fail. 2019;41(1):481–488.
   PubMed Web of Science ®Google Scholar
• Dorison A, Chantziantoniou C. DDR1: A major player in renal diseases. Cell Adh Migr. 2018;12(4):299–304.
   PubMed Web of Science ®Google Scholar
• Dzeshka MS, Lip GYH, Snezhitskiy V, et al. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–959.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang J, Bai Y, et al. Overview of microRNAs in cardiac hypertrophy, fibrosis, and apoptosis. IJMS. 2016;18(1):1–21.,
   Google Scholar
• Xie J, Yang L, Tian L, et al. Macrophage migration inhibitor factor upregulates MCP-1 expression in an autocrine manner in hepatocytes during acute mouse liver injury. Sci Rep. 2016;6:1–12.
   PubMed Web of Science ®Google Scholar
• Li J, Bao L, Zha D, et al. Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways. Int Immunopharmacol. 2018;55:9–19.
   PubMed Web of Science ®Google Scholar
• Andrikopoulos P, Kieswich J, Pacheco S, et al. The MEK inhibitor trametinib ameliorates kidney fibrosis by suppressing ERK1/2 and mTORC1 signaling. J Am Soc Nephrol. 2019;30(1):33–49.
   PubMed Web of Science ®Google Scholar
• Tesch GH, Ma FY, Nikolic-Paterson DJ. ASK1: a new therapeutic target for kidney disease. Am J Physiol Renal Physiol. 2016;311(2):F373–81.
   PubMed Web of Science ®Google Scholar
• V H, Titus AS, Cowling RT, et al. Collagen receptor cross-talk determines α-smooth muscle actin-dependent collagen gene expression in angiotensin II-stimulated cardiac fibroblasts. J Biol Chem. 2019;294(51):19723–19739.
   PubMed Web of Science ®Google Scholar
• Ren T, Zhang W, Liu X, et al. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia. J Pathol. 2014;234(4):526–537.
   PubMed Web of Science ®Google Scholar
• Lin KL, Chou CH, Hsieh SC, et al. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J Bone Miner Res. 2010;25(11):2489–2503.
   PubMed Web of Science ®Google Scholar
• Zhang K, Corsa CA, Ponik SM, et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol. 2013;15(6):677–687.
   PubMed Web of Science ®Google Scholar
• Avivi-Green C, Singal M, Vogel WF. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2006;174(4):420–427.
   PubMed Web of Science ®Google Scholar
• El Azreq MA, Kadiri M, Boisvert M, et al. Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway. Oncotarget. 2016;7(29):44975–44990.
   PubMedGoogle Scholar
• Lu KK, Trcka D, Bendeck MP. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src. Cardiovasc Pathol. 2011;20(2):71–76.
   PubMed Web of Science ®Google Scholar
• Nam H, Kundu A, Brinkley GJ, et al. PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. Matrix Biol. 2020;89:43–58.
   Google Scholar